Startup | May 04, 2026
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Bloom has pioneered a technology to transform plant waste into valuable chemical products
The funding round also saw participation from some of India's top angel investors and leading industry giants
The company plans to invest in technology, business development, product innovation, and development across India
The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
ALV-100 is a bifunctional fusion protein combining glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonism with glucagon-like peptide-1 receptor agonism
NTX-253 is a potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor
Subscribe To Our Newsletter & Stay Updated
